Elsevier

Placenta

Volume 31, Issue 8, August 2010, Pages 686-690
Placenta

Ethical Aspects of Human Placental Perfusion: Interview of the Mothers Donating Placenta

https://doi.org/10.1016/j.placenta.2010.05.005Get rights and content

Abstract

Within the EU project “NewGeneris” human placental perfusion has been used for assessing in utero fetal exposure to food carcinogens. Within the work package of ethical aspects of the research, we were interested in the way mothers who donated placentas for perfusion perceived their participation in the study. Thematic interviews were conducted with 25 mothers who had donated the placenta for placental perfusion studies. The main themes covered during the interviews were recruitment for placental perfusion studies, informed consent, risks and benefits, handling and confidentiality of personal information and societal meaning of the placental perfusion studies. Data were analysed qualitatively using thematic content analysis. Mothers, when rightly informed about the purpose of the placental perfusion study were very interested in the study and supported the use of the placenta for such purpose. Overall, this study revealed several points of particular interest in placental perfusion studies. First, the recruiters’ involvement with and commitment to the research project and its ethical conduct were of utmost importance for handling the informed consent procedure correctly. Second, the timing of the recruitment was important since it considerably affected the understanding of the given information, women in labour being obviously less receptive to such information. Third, the trust of participants depended on the multidisciplinary collaboration between the researchers and hospital personnel and this trust was enhanced by a thorough, objective and fair informed consent procedure.

Introduction

Research on ethics of studies involving pregnant women is sparse. Most studies target clinical trials in pregnant women where potential physical harm for both the mother and baby is the main objective [1], [2], [3]. However, while other types of research not directly related to medical side-effects or harm are still meagre, in any type of research pregnant women have been considered as a vulnerable group. According to the Declaration of Helsinki [4] and e.g., in the Finnish law [5] this fact has to be taken into consideration. Current research on informed consent deals mainly with women’s decisions on the mode of delivery [6], [7], [8], [9] genetic testing [10], [11], [12] or serum screening for a variety of diseases, such as HIV [13].

The participation in any study requires that the participants are fully competent to give consent for their participation. The consent must be a voluntary choice, and as a basis of this choice the participants need information presented to them in a manner they can comprehend. Thereafter, the putative participant can make his or her own choice to participate and thus authorise the research staff to act according to the plan [14]. Both autonomy and informed consent are also emphasised in the Finnish Act on the Status and Rights of Patients (785/1992) [5]. In different types of research informed consent may have a different meaning for the participant. For instance, it has been discussed whether the use of human tissue samples given anonymously or archived pathology samples requires specific informed consent [15]. Although a number of studies on healthy volunteers exist [16], [17] the number of perception studies is much less abundant [18].

Use of human placenta in biomedical research has increased in the past few years [19], [20], [21], [22]. The placenta and cord blood are known to be an important resource for stem cell research [23] and some research has already been conducted on ethical aspects of cord blood banking [24], [25]. According to the literature, mothers were willing to donate cord blood to be stored in a biobank with associated relevant information [24], [25]. Major future challenges are the consent for future biobank storage and unforeseen future research [26] as well as tissue exportation from the developing countries to the developed world [27].

Within an EU project NewGeneris (Contract no. FOOD-CT-2005–0163202) we have carried out human placental perfusions to study transplacental transfer and placental effects on placental metabolism of food carcinogens [28], [29]. During these studies, the term placenta was collected after the delivery of healthy women and the tissue remained anonymous. For the present study on ethical aspects of recruitment, mothers who previously agreed to participate in the placental perfusion research were interviewed.

The ethical aspects of human placental perfusion have been almost an unstudied field. In the literature, only one study could be identified using search terms “human placental perfusion” and “ethics” [18]. However, such data may contribute to both improving ethical conduct of recruitment and increasing participation in environmental health studies.

Section snippets

Recruitment to the interview study

Mothers who gave birth at the University Hospital of Kuopio and donated the placenta for the placental perfusion study were asked one day after delivery for consent to be interviewed at a later stage (Fig. 1). The complete study comprised 25 participants (Table 1). Participants met the following criteria: 1) able to give informed consent 2) Finnish speaking and 3) living in the area of the Hospital District of Northern Savo. In four cases the fathers were interviewed together with the mothers.

Recruitment for placental perfusion study

The recruitment to the placental perfusion study (see Fig. 1) took place at the hospital as planned in most cases by midwives. In three cases a student recruited the mother, and in five cases the mothers did not know who the recruiter was. Most of the mothers (18/25) considered hospital recruitment acceptable because the donated tissue was placenta. The other considered the possibility of recruitment before entering the hospital. Mothers were recruited in the placental perfusion studies in the

Discussion

The most important finding in this study was that mothers, when rightly informed about the purpose of placental perfusion study, in this case fetal exposure to carcinogens, were very interested in the study and supported the use of the placenta for such a purpose. Also, they were very willing to donate the placenta for this kind of scientific research. Delivery is a very sensitive situation and mothers had a variety of emotions at the time. Their main concerns were the baby, how to survive the

Role of the funding source

This study is funded by NewGeneris-project.

Conflict of interest

None.

Acknowledgements

We appreciate the participation of the mothers and the perfusion group in Kuopio: Vesa Karttunen, Kirsi Annola, Heidi Partanen.

References (39)

  • G.J. Jenkins et al.

    The importance of cultural considerations in the promotion of ethical research with human biologic material

    J Lab Clin Med

    (2005)
  • M.C. Audette et al.

    Placenta

    (2010)
  • V. Wild

    Plädoyer fur einen Einschluss schwangerer Frauen in Arzneimittelstudien

    EthikMed

    (2007)
  • C.L. Emmett et al.

    Women's experience of decision making about mode of delivery after a previous caesarean section: the role of health professionals and information about health risks

    BJOG

    (2006)
  • V. Bergeron

    The ethics of caesarean section on maternal request: a feminist critique of the American college of obstetricians and gynaecologists’ position on patient-choice surgery

    Bioethics

    (2007)
  • J.E. Potter et al.

    Women's autonomy and scheduled cesarean sections in Brazil: a cautionary tale

    Birth

    (2008)
  • I. Wiklund et al.

    Expectation and experiences of childbirth in primiparae with caesarean section

    BJOG

    (2007)
  • Cited by (24)

    • Activities of metabolizing enzymes in human placenta

      2020, Toxicology Letters
      Citation Excerpt :

      Information on gender, date of birth, gestational weeks and weight of the placenta, but no personal information were recorded. Collection of placentas for perfusion studies has been shown to produce no harm or risk to donating mothers (Halkoaho et al., 2010). All samples from perfusions are from earlier studies by our group.

    • Biomarkers of Toxicity in Human Placenta

      2019, Biomarkers in Toxicology
    • Criteria and challenges of the human placental perfusion - Data from a large series of perfusions

      2015, Toxicology in Vitro
      Citation Excerpt :

      No personal identifications have been retained. As studied by Halkoaho et al. (2010), in most cases mothers are very interested to participate in this kind of study when they are well informed. In all perfusions included in this paper, a dual re-circulating perfusion where both maternal and fetal side of a single cotyledon is perfused (Fig. 2) has been used (Annola et al., 2008; Karttunen et al., 2010; Partanen et al., 2010; Pienimäki et al., 1995).

    View all citing articles on Scopus
    View full text